These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8695863)

  • 1. LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies.
    Dent AL; Yewdell J; Puvion-Dutilleul F; Koken MH; de The H; Staudt LM
    Blood; 1996 Aug; 88(4):1423-6. PubMed ID: 8695863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.
    Ahn JH; Hayward GS
    J Virol; 1997 Jun; 71(6):4599-613. PubMed ID: 9151854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies.
    Ruthardt M; Orleth A; Tomassoni L; Puccetti E; Riganelli D; Alcalay M; Mannucci R; Nicoletti I; Grignani F; Fagioli M; Pelicci PG
    Oncogene; 1998 Apr; 16(15):1945-53. PubMed ID: 9591778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
    Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
    J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
    Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
    Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PML oncogenic domains (PODs) in human megakaryocytes.
    Drouin A; Schmitt A; Massé JM; Cieutat AM; Fichelson S; Cramer EM
    Exp Cell Res; 2001 Dec; 271(2):277-85. PubMed ID: 11716540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies.
    Zong RT; Das C; Tucker PW
    EMBO J; 2000 Aug; 19(15):4123-33. PubMed ID: 10921892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator.
    Bloch DB; Nakajima A; Gulick T; Chiche JD; Orth D; de La Monte SM; Bloch KD
    Mol Cell Biol; 2000 Aug; 20(16):6138-46. PubMed ID: 10913195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient mutations alter ATRX targeting to PML nuclear bodies.
    Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
    Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.
    Seeler JS; Marchio A; Losson R; Desterro JM; Hay RT; Chambon P; Dejean A
    Mol Cell Biol; 2001 May; 21(10):3314-24. PubMed ID: 11313457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.
    Sternsdorf T; Jensen K; Will H
    J Cell Biol; 1997 Dec; 139(7):1621-34. PubMed ID: 9412458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment.
    Seeler JS; Marchio A; Sitterlin D; Transy C; Dejean A
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7316-21. PubMed ID: 9636146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies.
    Komatsu T; Nagata K; Wodrich H
    J Virol; 2016 Feb; 90(3):1657-67. PubMed ID: 26608315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells.
    Kruse ML; Arlt A; Sieke A; Grohmann F; Grossmann M; Minkenberg J; Fölsch UR; Schäfer H
    J Biol Chem; 2005 Jul; 280(26):24849-56. PubMed ID: 15855159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular localization, expression, and structure of the nuclear dot protein 52.
    Sternsdorf T; Jensen K; Züchner D; Will H
    J Cell Biol; 1997 Jul; 138(2):435-48. PubMed ID: 9230084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
    Engelhardt OG; Ullrich E; Kochs G; Haller O
    Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
    Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
    J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional organization of promyelocytic leukemia nuclear bodies.
    Lang M; Jegou T; Chung I; Richter K; Münch S; Udvarhelyi A; Cremer C; Hemmerich P; Engelhardt J; Hell SW; Rippe K
    J Cell Sci; 2010 Feb; 123(Pt 3):392-400. PubMed ID: 20130140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not.
    Wiesmeijer K; Molenaar C; Bekeer IM; Tanke HJ; Dirks RW
    J Struct Biol; 2002; 140(1-3):180-8. PubMed ID: 12490166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.